SELLAS LIFE SCIENCES GROUP I's ticker is SLS and the CUSIP is 81642T209. A total of 31 filers reported holding SELLAS LIFE SCIENCES GROUP I in Q3 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,759 | +4.5% | 16,317 | +0.0% | 0.00% | – |
| Q2 2023 | $25,613 | +11.0% | 16,314 | +1.1% | 0.00% | – |
| Q1 2023 | $23,083 | -39.4% | 16,142 | +0.0% | 0.00% | – |
| Q4 2022 | $38,090 | +73.1% | 16,140 | +44.9% | 0.00% | – |
| Q3 2022 | $22,000 | -12.0% | 11,136 | -0.0% | 0.00% | – |
| Q2 2022 | $25,000 | -39.0% | 11,137 | +82.6% | 0.00% | – |
| Q1 2022 | $41,000 | +10.8% | 6,098 | -7.7% | 0.00% | – |
| Q4 2021 | $37,000 | 0.0% | 6,610 | +60.8% | 0.00% | – |
| Q3 2021 | $37,000 | -51.3% | 4,110 | -40.0% | 0.00% | – |
| Q2 2021 | $76,000 | +31.0% | 6,854 | +0.3% | 0.00% | – |
| Q1 2021 | $58,000 | – | 6,835 | +12327.3% | 0.00% | – |
| Q4 2020 | $0 | – | 55 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 55 | +22.2% | 0.00% | – |
| Q2 2020 | $0 | – | 45 | +18.4% | 0.00% | – |
| Q1 2020 | $0 | – | 38 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alyeska Investment Group, L.P. | 1,250,000 | $1,787,500 | 0.02% |
| Alyeska Investment Group, L.P. | 1,000,000 | $1,430,000 | 0.01% |
| Opus Capital Group, LLC | 25,000 | $36 | 0.01% |
| Equitable Holdings, Inc. | 130,000 | $185,900 | 0.00% |
| VANGUARD GROUP INC | 896,912 | $1,282,584 | 0.00% |
| WealthPLAN Partners, LLC | 1 | $1 | 0.00% |
| OSAIC HOLDINGS, INC. | 1,660 | $2,373 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 31,304 | $44,765 | 0.00% |
| WELLS FARGO & COMPANY/MN | 16,142 | $23,083 | 0.00% |
| NORTHERN TRUST CORP | 30,018 | $42,926 | 0.00% |